12559215

Source:http://linkedlifedata.com/resource/pubmed/id/12559215

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001792, umls-concept:C0016860, umls-concept:C0018801, umls-concept:C0030705, umls-concept:C0039155, umls-concept:C0205307, umls-concept:C0542341, umls-concept:C1280500, umls-concept:C2825032
pubmed:issue	1
pubmed:dateCreated	2003-1-31
pubmed:abstractText	In heart failure patients, diuretics cause renin-angiotensin-aldosterone system (RAS) activation, which may lead to increased morbidity and mortality despite short-term symptomatic improvement.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100887595
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Atrial Natriuretic Factor, http://linkedlifedata.com/resource/pubmed/chemical/Diuretics, http://linkedlifedata.com/resource/pubmed/chemical/Epinephrine, http://linkedlifedata.com/resource/pubmed/chemical/Furosemide, http://linkedlifedata.com/resource/pubmed/chemical/Neurotransmitter Agents, http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine, http://linkedlifedata.com/resource/pubmed/chemical/Renin
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1388-9842
pubmed:author	pubmed-author:HoefnagelsWillibrord H LWH, pubmed-author:JansenRené W M MRW, pubmed-author:SweepFred C G JFC, pubmed-author:van KraaijDave J WDJ
pubmed:issnType	Print
pubmed:volume	5
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	47-53
pubmed:dateRevised	2011-6-8
pubmed:meshHeading	pubmed-meshheading:12559215-Aged, pubmed-meshheading:12559215-Aldosterone, pubmed-meshheading:12559215-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:12559215-Atrial Natriuretic Factor, pubmed-meshheading:12559215-Blood Pressure, pubmed-meshheading:12559215-Body Weight, pubmed-meshheading:12559215-Diuretics, pubmed-meshheading:12559215-Double-Blind Method, pubmed-meshheading:12559215-Echocardiography, pubmed-meshheading:12559215-Epinephrine, pubmed-meshheading:12559215-Female, pubmed-meshheading:12559215-Follow-Up Studies, pubmed-meshheading:12559215-Furosemide, pubmed-meshheading:12559215-Heart Failure, pubmed-meshheading:12559215-Heart Rate, pubmed-meshheading:12559215-Humans, pubmed-meshheading:12559215-Male, pubmed-meshheading:12559215-Neurotransmitter Agents, pubmed-meshheading:12559215-Norepinephrine, pubmed-meshheading:12559215-Patient Compliance, pubmed-meshheading:12559215-Renin, pubmed-meshheading:12559215-Renin-Angiotensin System, pubmed-meshheading:12559215-Statistics as Topic, pubmed-meshheading:12559215-Stroke Volume, pubmed-meshheading:12559215-Substance Withdrawal Syndrome, pubmed-meshheading:12559215-Systole, pubmed-meshheading:12559215-Time Factors, pubmed-meshheading:12559215-Treatment Outcome, pubmed-meshheading:12559215-Ventricular Function, Left
pubmed:year	2003
pubmed:articleTitle	Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
pubmed:affiliation	Department of Cardiology, Academic Hospital Maastricht, Maastricht, The Netherlands. dvankraaij@hotmail.com
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't